Plan C. Shouldn’t this be a smaller capital raise if catalysts like FDA filing and first EU sales are coming up in the first half 2025. Assuming of course that Norse 8 is successful. Maybe 5M shares including 5M warrants?
What surprises me is that Russ Trenary was actually very confident at both the quarterly CC and the HC Wainwright event that OTLK would be fully funded by the end of 2025.